Agilex Biolabs Pty. Ltd., headquartered in Australia, is a leading provider of bioanalytical services, specialising in the pharmaceutical and biotechnology sectors. Founded in 2015, the company has rapidly established itself as a trusted partner for clients seeking high-quality laboratory services across major operational regions, including Asia-Pacific and North America. Agilex Biolabs offers a comprehensive range of services, including pharmacokinetics, bioanalytical testing, and method development, distinguished by their commitment to scientific excellence and regulatory compliance. Their state-of-the-art facilities and experienced team enable them to deliver precise and reliable results, positioning them as a key player in the bioanalytical landscape. With a focus on innovation and client satisfaction, Agilex Biolabs continues to achieve significant milestones, reinforcing its reputation as a leader in the industry.
How does Agilex Biolabs Pty. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Agilex Biolabs Pty. Ltd.'s score of 47 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Agilex Biolabs Pty. Ltd., headquartered in Australia, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Healius Limited, which may influence its climate commitments and reporting practices. As of now, Agilex Biolabs has not established any documented reduction targets or climate pledges. The lack of specific emissions data suggests that the company may be in the early stages of developing its sustainability strategy or reporting framework. Given its affiliation with Healius Limited, any climate initiatives or targets may be aligned with the parent company's sustainability goals. However, without explicit data or commitments from Agilex Biolabs, it is challenging to provide a detailed overview of its carbon emissions and climate commitments. In summary, Agilex Biolabs Pty. Ltd. is currently not disclosing emissions data or reduction targets, and its climate strategy may be influenced by its relationship with Healius Limited.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 6,585,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 25,881,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 0,000,000 | 0,000,000 |
Agilex Biolabs Pty. Ltd.'s Scope 3 emissions, which increased by 0% last year and increased by approximately 0% since 2023, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 18% of total emissions under the GHG Protocol, with "Fuel and Energy Related Activities" being the largest emissions source at 68% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Agilex Biolabs Pty. Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.